The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.
Feng-Min LiuYu-Fei GaoYanyan KongYihui GuanJinsen ZhangShuai-Hong LiDan YeWenyu WenChuantao ZuoWei HuaPublished in: BMC cancer (2021)
SUVmax on PET can predict IDH1 mutation with adequate sensitivity and specificity, as is supported by reduced glucose consumption in IDH1 mutant gliomas.